To recover your password please fill in your email address
Please fill in below form to create an account with us
10/01/19
We are very pleased to announce recent results from NHMRC awards to Investigators at the CTC. Congratulations to Ann Livingstone and Xanthi Coskinas on each being awarded an NHMRC PHD Scholarship. Rachael Morton, Lisa Askie and Mbathio Dieng were each successful in being awarded NHMRC Project Grants. We were also successful in being part of a new NHMRC CRE grant in translational breast cancer research.
|
CTC Chief Investigator |
Scheme |
Title |
Grant award |
|
Ann Livingstone |
NHMRC Postgraduate Scholarship |
The costs, benefits and patient and clinician preferences of adjuvant immunotherapy in melanoma (Health Economics) |
$84,106
|
|
Xanthi Coskinas |
NHMRC Postgraduate Scholarship |
Changes to design aspects of ongoing randomised controlled trials (RCT) |
$64,057 |
|
A/Prof Rachael Morton (CIA) |
NHMRC Project Grant |
Can symptom monitoring with feedback to clinicians improve the lives of people on dialysis? (SWIFT) |
$1,732,011 |
|
Prof Lisa Askie (CIA) |
NHMRC Project Grant |
Cord Clamping and Placental Transfusion at Preterm Birth: an individual participant data and network meta-analysis |
$354,872 |
|
Dr Mbathio Dieng (CIH) |
NHMRC Project Grant |
Can patient-led surveillance detect recurrent or new primary melanoma & reduce need for routinely scheduled follow-up? A Randomised Controlled Trial. |
$1,229,190 |
|
Prof John Simes (CII) |
NHMRC Centres of Research Excellence |
Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic |
$2,496,428 |
|
A/Prof Anand Hardikar (CIA) |
Danish Diabetes Academy Visiting Professorship |
Assessing and Simulating (Pre-)miRNA Expression (ASPiRE) Study |
$79,000 |
|
A/Prof Mustafa Khasraw (CIA) |
Cure Brain Cancer Grant |
Sequitur: SEQUential Immunotherapy in Underserved Rare cancers |
$500,000 |
|
A/Prof Mustafa Khasraw (CIE) |
ARC Grant |
Precision and the person. A sociological study of innovation in cancer care |
$470,000 |
|
Prof Kei Lui |
MRFF – Rare Diseases |
Does withholding enteral feeds around blood transfusion reduce the incidence of NEC in very preterm infants. The international WHEAT study. |
$1,606,000 |
|
Dr Craig Gedye COGNO |
MRFF – Brain Cancer |
MAGMA – Multi-Arm Glioblastoma Australasia Trial |
$2,422,000 |
|
Dr Hao-Wen Sim COGNO |
MRFF – Brain Cancer |
PICCOG – PARP and Immune Checkpoint Inhibitor Combination for relapsed IDH-mutant high grade glioma |
$1,391,000 |
|
Cancer Council WA |
Laboratory tests to understand why some patients with mesothelioma respond better to a combination of chemotherapy and immunotherapy |
$99,876 |
|
|
A/Prof Mustafa Khasraw (CID) Dr Sonia Yip (CIL)
|
MRFF:Australian Brain Cancer Mission - Innovative Clinical Trials |
LUMOS (Low & Intermediate Grade Glioma Umbrella Study of Molecular Guided Therapies) |
$502,558 |